Stockreport

Immune Pharmaceuticals reports FY results [Seeking Alpha]

IMMUNE PHARMACEUTICALS INC NE  (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations
PDF Immune Pharmaceuticals reports FY resultsImmune Pharmaceuticals (NASDAQ:IMNP): FY EPS of -$2.11Cash and Equivalents of $6.8M.Press ReleaseClick to subscribe to real-time [Read more]